SEC Form 4 · accession 0001140361-18-011629
Medpace Holdings, Inc. · MEDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jesse J Geiger
Officer — CFO & COO, Lab Operations
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001668397
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 30, 2017 | A | 7,407 | $0.00 | A | 7,407 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $32.05 | Feb 28, 2018 | A | 15,000 | A | — | Feb 28, 2025 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Shares acquired by an in-kind exchange of Issuer shares for investment units of Medpace Investors, LLC originally acquired by the Reporting Person upon exercise of Issuer options. The options, once exercised, were immediately exchanged for investment units in Medpace Investors, LLC as required by the Medpace Holdings, Inc. 2014 Equity Incentive Plan.
- F2The option vests on February 28, 2022, subject to the Reporting Person's continued employment with the Issuer.